Motion management during SBRT for oligometastatic cancer: Results of a prospective phase II trial-Reference-Cited by-同舟云学术

Motion management during SBRT for oligometastatic cancer: Results of a prospective phase II trial

Published:2016-06 Issue:3 Volume:119 Page:519-524
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Van den Begin Robbe,Engels Benedikt,Boussaer Marlies,Dhont Jennifer,Burghelea Manuela,Depuydt Tom,Poels Kenneth,Collen Christine,Gevaert Thierry,Verellen Dirk,Storme Guy,de Mey Johan,De Ridder Mark

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference28 articles.

1. Radical irradiation of extracranial oligometastases;Salama;J Clin Oncol,2014

2. Stereotactic body radiotherapy for oligometastases;Tree;Lancet Oncol,2013

3. Radiotherapy for liver metastases: a review of evidence;Høyer;Int J Radiat Oncol,2012

4. Single-dose radiosurgical treatment for hepatic metastases – therapeutic outcome of 138 treated lesions from a single institution;Habermehl;Radiat Oncol,2013

5. Phase II study of helical tomotherapy for oligometastatic colorectal cancer;Engels;Ann Oncol,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Body Radiotherapy for Lung Oligo-metastases: Systematic Review and International Stereotactic Radiosurgery Society Practice Guidelines;Lung Cancer;2023-08

2. Multi-institutional phase II study on the safety and efficacy of dynamic tumor tracking-stereotactic body radiotherapy for lung tumors;Radiotherapy and Oncology;2022-07

3. Radiotherapy respiratory motion management in hepatobiliary and pancreatic malignancies: a systematic review of patient factors influencing effectiveness of motion reduction with abdominal compression;Acta Oncologica;2022-05-25

4. The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease;Cancers;2022-04-18

5. Local control of stereotactic body radiotherapy with dynamic tumor tracking for lung tumors: a propensity score-matched analysis;Japanese Journal of Clinical Oncology;2022-01-21